Engineered therapy for blood clotting disorder shows early promise

An investigational treatment that mimics a key clotting enzyme is effective, safe, and may one day eliminate the need for blood products for people with the rare, life-threatening blood disease hereditary thrombotic thrombocytopenic purpura (TTP), according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH).

Engineered therapy for blood clotting disorder shows early promise

An investigational treatment that mimics a key clotting enzyme is effective, safe, and may one day eliminate the need for blood products for people with the rare, life-threatening blood disease ...

Thu 14 Sep 17 from Medical Xpress

Engineered therapy for blood clotting disorder shows early promise, Fri 15 Sep 17 from ScienceDaily

Engineered therapy for blood clotting disorder shows early promise, Thu 14 Sep 17 from Eurekalert

  • Pages: 1

Bookmark

Bookmark and Share